Agency Forms Undergoing Paperwork Reduction Act Review, 10484-10485 [2018-04742]
Download as PDF
<![CDATA[
amozie on DSK30RV082PROD with NOTICES
10484
Federal Register / Vol. 83, No. 47 / Friday, March 9, 2018 / Notices
public-comments. Postal mail addressed
to the Commission is subject to delay
due to heightened security screening. As
a result, we encourage you to submit
your comments online. To make sure
that the Commission considers your
online comment, you must file it at
https://ftcpublic.commentworks.com/
ftc/furrulespra1 by following the
instructions on the web based form. If
this Notice appears at https://
www.regulations.gov, you also may file
a comment through that website.
If you file your comment on paper,
write ‘‘Paperwork Reduction Act: FTC
File No. P072108’’ on your comment
and on the envelope, and mail your
comment to the following address:
Federal Trade Commission, Office of the
Secretary, 600 Pennsylvania Avenue
NW, Suite CC–5610 (Annex C),
Washington, DC 20580, or deliver your
comment to the following address:
Federal Trade Commission, Office of the
Secretary, Constitution Center, 400 7th
Street SW, 5th Floor, Suite 5610,
Washington, DC 20024. If possible,
submit your paper comment to the
Commission by courier or overnight
service.
Because your comment will be placed
on the publicly accessible FTC website
at https://www.ftc.gov, you are solely
responsible for making sure that your
comment does not include any sensitive
or confidential information. In
particular, your comment should not
include any sensitive personal
information, such as your or anyone
else’s Social Security number; date of
birth; driver’s license number or other
state identification number, or foreign
country equivalent; passport number;
financial account number; or credit or
debit card number. You are also solely
responsible for making sure that your
comment does not include any sensitive
health information, such as medical
records or other individually
identifiable health information. In
addition, your comment should not
include any ‘‘trade secret or any
commercial or financial information
which . . . is privileged or
confidential’’—as provided by Section
6(f) of the FTC Act, 15 U.S.C. 46(f), and
FTC Rule 4.10(a)(2), 16 CFR 4.10(a)(2)—
including in particular competitively
sensitive information such as costs,
sales statistics, inventories, formulas,
patterns, devices, manufacturing
processes, or customer names.
Comments containing material for
which confidential treatment is
requested must be filed in paper form,
must be clearly labeled ‘‘Confidential,’’
and must comply with FTC Rule 4.9(c).
In particular, the written request for
confidential treatment that accompanies
VerDate Sep<11>2014
16:47 Mar 08, 2018
Jkt 244001
the comment must include the factual
and legal basis for the request, and must
identify the specific portions of the
comment to be withheld from the public
record. See FTC Rule 4.9(c). Your
comment will be kept confidential only
if the General Counsel grants your
request in accordance with the law and
the public interest. Once your comment
has been posted on the public FTC
website—as legally required by FTC
Rule 4.9(b)—we cannot redact or
remove your comment from the FTC
website, unless you submit a
confidentiality request that meets the
requirements for such treatment under
FTC Rule 4.9(c), and the General
Counsel grants that request.
Visit the Commission website at
https://www.ftc.gov to read this Notice.
The FTC Act and other laws that the
Commission administers permit the
collection of public comments to
consider and use in this proceeding as
appropriate. The Commission will
consider all timely and responsive
public comments that it receives on or
before May 8, 2018. You can find more
information, including routine uses
permitted by the Privacy Act, in the
Commission’s privacy policy, at https://
www.ftc.gov/site-information/privacypolicy.
David C. Shonka,
Acting General Counsel.
[FR Doc. 2018–04825 Filed 3–8–18; 8:45 am]
BILLING CODE 6750–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–18–0199]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Application for
Permit to Import Biological Agents and
Vectors of Human Disease into the
United States and Application for
Permit to Import or Transport Live Bats
(42 CFR 71.54) to the Office of
Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on
September 26, 2017 to obtain comments
from the public and affected agencies.
CDC received three comments related to
the previous notice. This notice serves
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
to allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
Proposed Project
Import Permit Applications (42 CFR
71.54) (OMB Control Number 0920–
0199, expires 12/31/2019)—Revision—
Office of Public Health Preparedness
and Response (OPHPR), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
On September 26, 2017, CDC
published a 60-day Federal Register
notice (82 FR 44795) seeking public
comments to initiate a revision of the
information collection projects titled
‘‘Application for Permit to Import
Biological Agents, Infectious Substances
and Vectors of Human Disease into the
United States’’ and ‘‘Application for
Permit to Import or Transport Live
Bats.’’ As a result of this notice, CDC
received three comments. One
commenter requested that we make the
‘‘Application for Permit to Import
E:\FR\FM\09MRN1.SGM
09MRN1
10485
Federal Register / Vol. 83, No. 47 / Friday, March 9, 2018 / Notices
Biological Agents, Infectious Substances
and Vectors of Human Disease into the
United States’’ form fillable so that
applicants are able to complete the
electronically. We made no changes
based on this comment but note that the
form will be published as a pdf-fillable
form so that applicants have the ability
to save the document to the applicant’s
local drive, complete the form, and then
mail or fax the application to CDC. The
other two comments did not pertain to
the changes to the forms. Therefore, we
made no changes to forms based on
these comments.
The Application for Permit to Import
Biological Agents, Infectious Substances
and Vectors of Human Disease into the
United States form is used by laboratory
facilities, such as those operated by
government agencies, universities, and
research institutions to request a permit
for the importation of biological agents,
infectious substances, or vectors of
human disease. This form has been
revised to remove questions that are
duplicative or not required to process
the import permit request and added
questions requesting biosafety officer’s
contact information and verifying
biosafety measures for any subsequent
transfers listed on the import permit
application of infectious biological
agent, infectious substance, and/or
vector once in the United States.
The Application for Permit to Import
or Transport Live Bats form is used by
laboratory facilities such as those
operated by government agencies,
universities, research institutions, and
for educational, exhibition or scientific
purposes to request a permit for the
importation, and any subsequent
distribution after importation, of live
bats. This form currently requests the
applicant and sender contact
information; a description and intended
use of bats to be imported; and facility
isolation and containment information.
CDC revised this application to add a
question about what personal protective
measures will be used.
Estimates of burden for the survey are
based on information obtained from the
CDC import permit database on the
number of permits issued on annual
basis since 2010. CDC estimates 1,322
burden hours for this collection.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Form name
Applicants Requesting to Import Biological
Agents, Infectious Substances and Vectors.
Application for Permit to Import Biological
Agents, Infectious Substances and Vectors
of Human Disease into the United States.
Application for Permit to Import Biological
Agents, Infectious Substances and Vectors
of Human Disease into the United States
Guidance.
Application for Permit to Import Biological
Agents, Infectious Substances and Vectors
of Human Disease into the United StatesSubsequent Transfer.
Application for a Permit to Import Live Bats ..
Application for a Permit to Import Live Bats
Guidance.
Applicants Requesting to Import Biological
Agents, Infectious Substances and Vectors.
Applicants Requesting to Import Biological
Agents, Infectious Substances and Vectors.
Applicants Requesting to Import Live Bats ....
Applicants Requesting to Import Live Bats ....
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2018–04742 Filed 3–8–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–18–18EV]
amozie on DSK30RV082PROD with NOTICES
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Enhanced
Surveillance for Histoplasmosis to the
Office of Management and Budget
VerDate Sep<11>2014
16:47 Mar 08, 2018
Jkt 244001
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on December 21, 2017 to obtain
comments from the public and affected
agencies. CDC did not receive comments
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden per
response
(in hours)
2,000
1
20/60
2,000
1
10/60
380
1
50/60
10
10
1
1
20/60
10/60
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
E:\FR\FM\09MRN1.SGM
09MRN1
]]>Agencies
[Federal Register Volume 83, Number 47 (Friday, March 9, 2018)]
[Notices]
[Pages 10484-10485]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-04742]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-18-0199]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled Application for Permit to Import Biological
Agents and Vectors of Human Disease into the United States and
Application for Permit to Import or Transport Live Bats (42 CFR 71.54)
to the Office of Management and Budget (OMB) for review and approval.
CDC previously published a ``Proposed Data Collection Submitted for
Public Comment and Recommendations'' notice on September 26, 2017 to
obtain comments from the public and affected agencies. CDC received
three comments related to the previous notice. This notice serves to
allow an additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to [email protected]. Direct written comments
and/or suggestions regarding the items contained in this notice to the
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide
written comments within 30 days of notice publication.
Proposed Project
Import Permit Applications (42 CFR 71.54) (OMB Control Number 0920-
0199, expires 12/31/2019)--Revision--Office of Public Health
Preparedness and Response (OPHPR), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
On September 26, 2017, CDC published a 60-day Federal Register
notice (82 FR 44795) seeking public comments to initiate a revision of
the information collection projects titled ``Application for Permit to
Import Biological Agents, Infectious Substances and Vectors of Human
Disease into the United States'' and ``Application for Permit to Import
or Transport Live Bats.'' As a result of this notice, CDC received
three comments. One commenter requested that we make the ``Application
for Permit to Import
[[Page 10485]]
Biological Agents, Infectious Substances and Vectors of Human Disease
into the United States'' form fillable so that applicants are able to
complete the electronically. We made no changes based on this comment
but note that the form will be published as a pdf-fillable form so that
applicants have the ability to save the document to the applicant's
local drive, complete the form, and then mail or fax the application to
CDC. The other two comments did not pertain to the changes to the
forms. Therefore, we made no changes to forms based on these comments.
The Application for Permit to Import Biological Agents, Infectious
Substances and Vectors of Human Disease into the United States form is
used by laboratory facilities, such as those operated by government
agencies, universities, and research institutions to request a permit
for the importation of biological agents, infectious substances, or
vectors of human disease. This form has been revised to remove
questions that are duplicative or not required to process the import
permit request and added questions requesting biosafety officer's
contact information and verifying biosafety measures for any subsequent
transfers listed on the import permit application of infectious
biological agent, infectious substance, and/or vector once in the
United States.
The Application for Permit to Import or Transport Live Bats form is
used by laboratory facilities such as those operated by government
agencies, universities, research institutions, and for educational,
exhibition or scientific purposes to request a permit for the
importation, and any subsequent distribution after importation, of live
bats. This form currently requests the applicant and sender contact
information; a description and intended use of bats to be imported; and
facility isolation and containment information. CDC revised this
application to add a question about what personal protective measures
will be used.
Estimates of burden for the survey are based on information
obtained from the CDC import permit database on the number of permits
issued on annual basis since 2010. CDC estimates 1,322 burden hours for
this collection.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Applicants Requesting to Import Application for Permit to 2,000 1 20/60
Biological Agents, Infectious Import Biological Agents,
Substances and Vectors. Infectious Substances and
Vectors of Human Disease
into the United States.
Applicants Requesting to Import Application for Permit to 2,000 1 10/60
Biological Agents, Infectious Import Biological Agents,
Substances and Vectors. Infectious Substances and
Vectors of Human Disease
into the United States
Guidance.
Applicants Requesting to Import Application for Permit to 380 1 50/60
Biological Agents, Infectious Import Biological Agents,
Substances and Vectors. Infectious Substances and
Vectors of Human Disease
into the United States-
Subsequent Transfer.
Applicants Requesting to Import Application for a Permit to 10 1 20/60
Live Bats. Import Live Bats.
Applicants Requesting to Import Application for a Permit to 10 1 10/60
Live Bats. Import Live Bats Guidance.
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2018-04742 Filed 3-8-18; 8:45 am]
BILLING CODE 4163-18-P
